Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Parasitic”

284 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 284 results

Not applicableStudy completedNCT03517462
What this trial is testing

Ocular Changes After Ivermectin - (DOLF IVM/Oncho)

Who this might be right for
Onchocerciasis
Washington University School of Medicine 231
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Not applicableStudy completedNCT03435419
What this trial is testing

Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in Afghanistan

Who this might be right for
Cutaneous Leishmaniases
Foundation for Innovative New Diagnostics, Switzerland 274
Testing effectiveness (Phase 2)WithdrawnNCT01035619
What this trial is testing

Pediatric Pharmacokinetics And Safety Study Of Moxidectin

Who this might be right for
Onchocerciasis
Pfizer
Not applicableStudy completedNCT03641339
What this trial is testing

Defining Skin Immunity of a Bite of Key Insect Vectors in Humans

Who this might be right for
ZikaDengueMalaria+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 95
Large-scale testing (Phase 3)Study completedNCT01381055
What this trial is testing

Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Paulo Roberto Lima Machado 164
Not applicableStudy completedNCT02032043
What this trial is testing

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)

Who this might be right for
Lymphatic FilariasisOnchocerciasisSoil Transmitted Helminth (STH) Infections
Washington University School of Medicine 14,457
Not applicableUnknownNCT05783778
What this trial is testing

Evaluation of the Role of Latent Toxoplasmosis in Female Patients With Active Acne Vulgaris

Who this might be right for
Acne VulgarisToxoplasmosis
Sohag University 200
Not applicableUnknownNCT03653975
What this trial is testing

Clinical Features and Potential Etiology of Epilepsy and Nodding Syndrome in the Mahenge Area, Ulanga District

Who this might be right for
Nodding SyndromeEpilepsyOnchocerciasis+1 more
Heidelberg University 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT06070116
What this trial is testing

Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis

Who this might be right for
Onchocercal Subcutaneous NoduleOnchocerciasisOnchocerciasis, Ocular+2 more
Washington University School of Medicine 300
Early research (Phase 1)Study completedNCT01484548
What this trial is testing

Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers

Who this might be right for
Leishmaniasis
Access to Advanced Health Institute (AAHI) 36
Testing effectiveness (Phase 2)Study completedNCT02094716
What this trial is testing

A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies

Who this might be right for
Scabies
Mylan Inc. 130
Testing effectiveness (Phase 2)Study completedNCT06449040
What this trial is testing

Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly

Who this might be right for
Cutaneous Leishmaniasis, American
Hospital Universitário Professor Edgard Santos 28
Post-approval studies (Phase 4)Study completedNCT02775617
What this trial is testing

Azithromycin - Ivermectin Mass Drug Administration for Skin Disease

Who this might be right for
ScabiesYawsImpetigo
London School of Hygiene and Tropical Medicine 1,291
Testing effectiveness (Phase 2)Study completedNCT00600548
What this trial is testing

Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)

Who this might be right for
Treatment of Cutaneous Leishmaniasis in Brazil.
Hospital Universitário Professor Edgard Santos 180
Very early researchUnknownNCT06546579
What this trial is testing

Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study

Who this might be right for
Scabies
Radboud University Medical Center 144
Not applicableLooking for participantsNCT06793111
What this trial is testing

Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)

Who this might be right for
Leishmaniasis, Visceral
IRCCS Azienda Ospedaliero-Universitaria di Bologna 300
Large-scale testing (Phase 3)Study completedNCT06917040
What this trial is testing

Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria

Who this might be right for
Leishmaniasis, CutaneousVector Borne Diseases
The Mentor Initiative 18,404
Testing effectiveness (Phase 2)Study completedNCT01377974
What this trial is testing

Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis

Who this might be right for
LeishmaniasisLeishmaniasis, Mucocutaneous
Brasilia University Hospital 40
Early research (Phase 1)Study completedNCT02661178
What this trial is testing

First in Man Clinical Trial of Emodepside (BAY 44-4400)

Who this might be right for
Healthy Volunteers
Drugs for Neglected Diseases 79
Next Page